Figure 1.

Mean plasma glucagon and glucose concentrations from 0 to 240 minutes after subcutaneous administration of glucagon in an autoinjector (GAI) or in a prefilled syringe (G-PFS; study A).
Abbreviations: GAI-BG, plasma glucose for participants administered glucagon as GAI; GAI-PK, plasma glucagon for participants administered glucagon as GAI; G-PFS-BG, plasma glucose for participants administered glucagon as G-PFS; G-PFS-PK, plasma glucagon in participants administered glucagon as G-PFS.